Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies
BRISBANE, Calif. & CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)– Maverick Therapeutics Inc., an MPM Capital portfolio company, and Takeda Pharmaceutical Company Limited(TSE:4502) announced today that...